Walpar Nutritions Share Price Today | Stock Price & Walpar Nutritions Share Screener
Track the current Walpar Nutritions share price and stock price live with TickJournal's free stock screener. Check WALPAR yearly price range for the annual price range and momentum. Use the Walpar Nutritions stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Walpar Nutritions opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Walpar Nutritions Share Price Chart
Track the current stock price of Walpar Nutritions with an interactive chart. Analyse WALPAR share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Walpar Nutritions stock quote in one place.
Walpar Nutritions Company Profile - Fundamental Screener
Screen Walpar Nutritions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for WALPAR shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0G2G01015.
Company Details
Classification
Identifiers and Leadership
Walpar Nutritions Balance Sheet Screener
Screen WALPAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹47, up from ₹37 in 2024.
Latest statistics put total assets at ₹47 and shareholder funds at ₹19, with a leverage ratio of 0.72.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 47 | 37 | 34 | 28 | 18 |
| Current Assets | 35 | 25 | 24 | 19 | 15 |
| Fixed Assets | 11 | 10 | 10 | 2 | 2 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 4 | 6 | 2 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 19 | 16 | 14 | 13 | 5 |
| Share Capital | 9 | 5 | 5 | 5 | 3 |
| Reserves & Surplus | 7 | 10 | 7 | 7 | 1 |
Walpar Nutritions Income Statement Screener - Profit & Revenue Analysis
Screen Walpar Nutritions income statement and profit fundamentals. Analyze WALPAR quarterly results. Walpar Nutritions reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹72 and net profit of ₹3.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
Revenue and Expenses | ||||||
| Revenue | 0 | 72 | 63 | 36 | 27 | 6 |
| Expenses | 0 | 66 | 58 | 32 | 26 | 6 |
Operating Costs and Margins | ||||||
| EBITDA | 0 | 6 | 5 | 4 | 1 | 1 |
| Operating Profit % | 0.00% | 8.00% | 8.00% | 10.00% | 4.00% | 8.00% |
| Depreciation | 0 | 2 | 2 | 2 | 0 | 0 |
| Interest | 0 | 0 | 1 | 1 | 1 | 0 |
Profit and Earnings | ||||||
| Profit Before Tax | 0 | 4 | 3 | 1 | 0 | 0 |
| Tax | 0 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 0 | 3 | 2 | 1 | 0 | 0 |
| EPS | 0.00 | 2.48 | 1.69 | 1.40 | 0.84 | 0.46 |
Walpar Nutritions Cash Flow Screener - Liquidity Fundamentals
Screen WALPAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹4, and net cash flow was an inflow of ₹1.
Over the same period, investing activities used ₹2 and financing activities used ₹1.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
Cash from Operations and Investing | |||||
| Operating Activities | 4 | 5 | 1 | -1 | 0 |
| Investing Activities | -2 | -4 | -3 | -6 | -2 |
Financing and Net Cash | |||||
| Financing Activities | -1 | -2 | 2 | 7 | 3 |
| Net Cash Flow | 1 | 0 | 0 | -1 | 1 |
Walpar Nutritions Shareholding Pattern Screener
See Walpar Nutritions shareholding pattern with promoter, FII, and DII holdings. Check Walpar Nutritions promoter holding and ownership changes for WALPAR on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 68.52%, foreign institutions 0.00%, domestic institutions 0.00% and the public 22.58%, spread across 333 shareholders.
The shareholder count was 333 in 2025-Mar, compared with 345 in 2025-Sept.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-May | 2023-Sept | 2022-Mar |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 68.52% | 68.61% | 71.23% | 68.44% | 70.54% | 71.46% | 71.46% | 71.02% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 22.58% | 23.39% | 20.98% | 22.70% | 22.81% | 21.64% | 21.34% | 27.17% |
| Other Holding | 8.90% | 8.01% | 7.80% | 8.86% | 6.65% | 6.90% | 7.20% | 1.81% |
| Shareholder Count | 333 | 345 | 226 | 335 | 270 | 258 | 233 | 460 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Walpar Nutritions. Walpar Nutritions dividend yield can be compared with peers and other stocks in the market.
Walpar Nutritions Stock Index Membership - Nifty & Sensex
See which indices include Walpar Nutritions stock. Check WALPAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Walpar Nutritions Market Events Screener - Corporate Actions
Get Walpar Nutritions corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Walpar Nutritions stock events that may affect WALPAR share price, along with derivatives, futures and options activity and sector gainers.
5 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2025, with a record date of November 13, 2025.
It is followed by Quarterly Result Announcement dated May 15, 2025 and Quarterly Result Announcement dated November 12, 2024.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 4.32% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | -4.14% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -1.01% |
| 2024-08-14 | 2024-08-14 | Bonus | 1:1 | 7.04% |
| 2024-07-30 | 2024-07-30 | Annual General Meeting | NA | -1.57% |
Walpar Nutritions Competitors Screener - Peer Stocks Comparison
Screen WALPAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 426,386 | 38.21 | 54,729 | 9.71% | 10,980 | 53.49 |
| Divis Laboratories | 161,936 | 64.01 | 9,712 | 18.67% | 2,191 | 43.80 |
| Torrent Pharmaceuticals | 144,523 | 62.70 | 11,539 | 6.99% | 1,911 | 50.03 |
| Dr Reddys Laboratories | 108,410 | 19.25 | 33,741 | 16.73% | 5,725 | 53.38 |
| Lupin | 106,092 | 22.06 | 22,910 | 13.74% | 3,306 | 56.84 |
| Cipla | 101,488 | 22.07 | 28,410 | 7.12% | 5,291 | 31.85 |
| Zydus Life Science | 89,605 | 17.54 | 23,511 | 18.55% | 4,615 | 45.58 |
| Mankind Pharma | 82,561 | 45.82 | 12,744 | 20.90% | 2,007 | 37.22 |
| Aurobindo Pharma | 75,005 | 20.80 | 32,346 | 9.43% | 3,484 | 60.75 |
| Alkem Laboratories | 62,861 | 25.87 | 13,458 | 3.70% | 2,216 | 37.74 |
Walpar Nutritions Company Announcements - News & Reports Screener
Screen WALPAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 2.58. Market capitalisation stands at ₹42.73 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 6 income statement periods, 5 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.